WTO 'expected to announce' 17-year drug patent waiver for LDCs

The World Trade Organization (WTO) is expected to announce a 17-year extension to an agreement that exempts the world’s Least Developed Countries (LDCs) from a duty to grant patents covering pharmaceutical drugs, an activist group has claimed.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Africa

WTO confirms 17-year extension to LDC patent waiver

6 November 2015 The World Trade Organization has granted permission for the world’s Least Developed Countries to be exempt from administering and enforcing patents directed to pharmaceutical drugs.

Biotechnology

WTO fails to strike deal to waive COVID-19 IP

20 October 2020 Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation to conclude an agreement.

More on this story

Africa

WTO confirms 17-year extension to LDC patent waiver

6 November 2015 The World Trade Organization has granted permission for the world’s Least Developed Countries to be exempt from administering and enforcing patents directed to pharmaceutical drugs.

Biotechnology

WTO fails to strike deal to waive COVID-19 IP

More on this story

Africa

WTO confirms 17-year extension to LDC patent waiver

6 November 2015 The World Trade Organization has granted permission for the world’s Least Developed Countries to be exempt from administering and enforcing patents directed to pharmaceutical drugs.

Biotechnology

WTO fails to strike deal to waive COVID-19 IP